Myristoylation increases the CD8+T-cell response to a GFP prototype antigen delivered by modified vaccinia virus Ankara.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of General Virology

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/jgv.0.000425PMID 26864442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deciphering Poxvirus Gene Expression by RNA Sequencing and Ribosome Profiling

  2015influential reference
• Recombinant modified vaccinia virus Ankara-based malaria vaccines

  2015cited by this paper
• Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8+ T Cell Epitope

  2014cited by this paper
• Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

  2014cited by this paper
• Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

  2014cited by this paper
• Clinical applications of attenuated MVA poxvirus strain

  2013cited by this paper
• Clinical development of Modified Vaccinia virus Ankara vaccines.

  2013cited by this paper
• Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies.

  2013cited by this paper
• Poxvirus vectors.

  2013cited by this paper
• Critical Role of Perforin-dependent CD8+ T Cell Immunity for Rapid Protective Vaccination in a Murine Model for Human Smallpox

  2012influential reference
• Easy and efficient protocols for working with recombinant vaccinia virus MVA.

  2012influential reference
• Interplay between Modified Vaccinia Virus Ankara and Dendritic Cells: Phenotypic and Functional Maturation of Bystander Dendritic Cells

  2011cited by this paper
• Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity

  2011cited by this paper
• Memories that last forever: strategies for optimizing vaccine T-cell memory.

  2010cited by this paper
• Preclinical Studies of a Modified Vaccinia Virus Ankara-Based HIV Candidate Vaccine: Antigen Presentation and Antiviral Effect

  2010cited by this paper
• Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model

  2010cited by this paper
• Prospects for an influenza vaccine that induces cross‐protective cytotoxic T lymphocytes

  2009cited by this paper
• Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions.

  2007cited by this paper
• Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination

  2007cited by this paper
• Cross-Priming of Cytotoxic T Cells Dictates Antigen Requisites for Modified Vaccinia Virus Ankara Vector Vaccines

  2007influential reference
• Poxvirus CD8+ T-Cell Determinants and Cross-Reactivity in BALB/c Mice

  2006cited by this paper
• Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity.

  2006cited by this paper
• N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.

  2002cited by this paper
• The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal

  1997cited by this paper
• Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.

  1997cited by this paper
• A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.

  1994cited by this paper
• Nonreplicating vaccinia vector efficiently expresses recombinant genes.

  1992cited by this paper
• Promoter DNA contacts made by the vaccinia virus early transcription factor.

  1991cited by this paper
• The complete DNA sequence of vaccinia virus.

  1990cited by this paper
• Vaccinia virus: a selectable eukaryotic cloning and expression vector.

  1982cited by this paper
• Identification and Characterization of Three Immunodominant Structural Proteins of Fowlpox Virus

  year unknowncited by this paper

• Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice

  2023cites this paper
• A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice

  2019cites this paper
• A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.

  2017cites this paper
• Viral vector-based influenza vaccines

  2016cites this paper